Mikael Dolsten - 02 Mar 2026 Form 3 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Mikael Dolsten
Issuer symbol
APLS
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
3
Filing time
03 Mar 2026, 16:05:37 UTC
Previous filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dolsten Mikael Director C/O APELLIS PHARMACEUTICALS, INC., WALTHAM /s/ David Watson, attorney-in-fact for Mikael Dolsten 03 Mar 2026 0001437590

No securities are beneficially owned.